Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples